Media

Unilever brings holding group creative teams together for new agency model trial

Unilever brings holding group creative teams together for new agency model trial

Unilever is trialling a new agency model which will see creative agency talent within a holding group integrated into a single team.

FBI probes media trading practices in the US

FBI probes media trading practices in the US

By

The Federal Bureau of Investigation is looking into media trading and transparency in the US advertising market.

Rethinking disability targeting

Rethinking disability targeting

If we properly and intentionally use the power of targeted marketing on behalf of our disabled customers, we might drive real value for an audience we've ignored for too long.

GSK reviews $1.76 billion global media

GSK reviews $1.76 billion global media

By

Pharma giant GlaxoSmithKline has reportedly launched a review of its $1.76 billion global media agency arrangements, putting MediaCom and PHD on alert.

Trust in health sector takes a hit in major markets, Edelman research finds

Trust in health sector takes a hit in major markets, Edelman research finds

By

The healthcare sector has suffered a dip in public trust in major markets including France, India and the US, but Britons remain among the more trusting globally, according to the Edelman Health Trust Barometer.

Marketers share how they use ad safety tech to help pharma clients feel comfortable

Marketers discuss the role of ad safety tech in helping pharma clients feel comfortable with ads in non-endemic media.

Karthic Bala, Condé Nast

Karthic Bala, Condé Nast

Karthic Bala is head of data strategy at Condé Nast.

Susan Dorfman, CMI/Compas

Susan Dorfman, CMI/Compas

Susan Dorfman is chief commercial officer of CMI/Compas.

Donna Murphy, Havas Health & You

Donna Murphy, Havas Health & You

Donna Murphy is global CEO of Havas Health & You.

IPG CEO praises 'range of agencies' for Q1 revenue growth

IPG CEO praises 'range of agencies' for Q1 revenue growth

The strong start to 2018 means the firm is on track to hit financial targets for the year, said Michael Roth.

How Adapt Pharma tackled the opioid crisis head on

How Adapt Pharma tackled the opioid crisis head on

By

The firm's Narcan product is more than just a lifesaving treatment for opioid overdose. It's a brilliant, salient campaign, as well.

Shortening the drug side-effect list, and five other ways pharma DTC is set to be reformed

Shortening the drug side-effect list, and five other ways pharma DTC is set to be reformed

By

MM&M hosted an event in Boston devoted to discussing topics and trends for the DTC marketer.

Omnicom beats estimates in Q1, but sees slight dip in North America

Omnicom beats estimates in Q1, but sees slight dip in North America

Omnicom's healthcare revenue was up 2.7% in Q1

National Psoriasis Foundation partners with Remedy Health Media

National Psoriasis Foundation partners with Remedy Health Media

By

The two organizations will partner on content including personal stories and expert advice.

Global adspend growth to accelerate to 4.7% in 'stellar' 2018

Global adspend growth to accelerate to 4.7% in 'stellar' 2018

By

Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).

Back to the Future:  Print media thrives in point of care

Back to the Future: Print media thrives in point of care

By

Not only isn't print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it's thriving in a most unlikely environment: the point of care

What Facebook's news feed changes mean for brands and publishers

What Facebook's news feed changes mean for brands and publishers

By

Facebook's decision to reprioritise its news feed to favour "social interactions" over other forms of content may please its users but will be challenging for brands.

MM&M's 5 most-read agency stories of 2017

MM&M's 5 most-read agency stories of 2017

By

The agency issue, people moves, and a series of restructures top the list.

Rejuvenan Global Health names Hudson Cutler communications AOR

Rejuvenan Global Health names Hudson Cutler communications AOR

By

The digital health startup was founded in 2015.

GroupM unveils upbeat global adspend forecast for 2018

GroupM unveils upbeat global adspend forecast for 2018

By

GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.

Five things for pharma marketers to know: Wednesday, November 22, 2017

Five things for pharma marketers to know: Wednesday, November 22, 2017

WebMD reportedly lays off 10% of workforce; Roche blocks Herceptin biosimilar with patent suit; insurers cover Collegium's Xtampza over Purdue's OxyContin

PRWeek and MM&M hire NBC exec for custom content role

PRWeek and MM&M hire NBC exec for custom content role

By

Emmy-nominated Maia Samuel becomes executive director of expanded Haymarket Content Lab; Bernadette Casey promoted to executive director of Haymarket Content Hub.

Accessible website design for users with disabilities lags far behind demand

Accessible website design for users with disabilities lags far behind demand

By

Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.

Media is where agencies are hurting

Media is where agencies are hurting

By

Why is revenue growth at some of the agency groups lagging forecasts for global ad expenditure?

Pharma's $6 billion annual ad spend targeted by media publishers

Pharma's $6 billion annual ad spend targeted by media publishers

By

Condé Nast, Time Inc., and Vice Media have all recently launched health content businesses.

Point-of-care group rolls out guidelines

Point-of-care group rolls out guidelines

By

The goal is to further cement point of care as a mainstream media channel.

New ANA report finds 'transparency concerns' in production process

New ANA report finds 'transparency concerns' in production process

By

In a follow-up to last year's media report, the Association of National Advertisers details "dysfunction" and rigged bids.

WebMD sells to private equity firm KKR

WebMD sells to private equity firm KKR

By

The deal is worth roughly $2.8 billion.

Five things for pharma marketers to know: Wednesday, July 5, 2017

Five things for pharma marketers to know: Wednesday, July 5, 2017

By

Amgen and Teva raise prices of leukemia drugs twice this year; Roche acquires diabetes app; docs use Snapchat to share patient scans

Roundtable: When it comes to media, pharma compares the new with the old

Roundtable: When it comes to media, pharma compares the new with the old

By

In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.